Log in

NASDAQ:IKNXIKONICS Stock Price, Forecast & News

$3.41
-0.03 (-0.87 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.39
Now: $3.41
$3.62
50-Day Range
$3.10
MA: $3.49
$4.94
52-Week Range
$2.83
Now: $3.41
$8.84
Volume9,273 shs
Average Volume10,046 shs
Market Capitalization$6.74 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79
IKONICS Corporation develops, manufactures, and sells photosensitive liquids and films for screen printing, awards and recognition, and dye sublimation markets worldwide. It operates through five segments: Domestic, Export, IKONICS Imaging, Digital Texturing Technology, and Advanced Material Solutions. The company sells screen printing films, emulsions, and inkjet receptive films to distributors; and photo resistant films, art supplies, glass, metal medium, and related abrasive etching equipment to end user customers. It also provides sound deadening technology to the aerospace industry; products and services for etched composites, ceramics, glass, and silicon wafers; and products related to proprietary inkjet technology used for mold texturing and prototyping. IKONICS Corporation markets and sells its products directly, as well as through domestic and international distributors, magazine advertising, trade shows, and the Internet. The company was formerly known as The Chromaline Corporation and changed its name to IKONICS Corporation in December 2002. IKONICS Corporation was founded in 1952 and is headquartered in Duluth, Minnesota.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.61 out of 5 stars


Industry, Sector and Symbol

Industry Photographic equipment & supplies
Sub-IndustryN/A
Current SymbolNASDAQ:IKNX
CUSIPN/A
Phone218-628-2217

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.62 million
Book Value$6.20 per share

Profitability

Net Income$-810,000.00

Miscellaneous

Employees82
Market Cap$6.74 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive IKNX News and Ratings via Email

Sign-up to receive the latest news and ratings for IKNX and its competitors with MarketBeat's FREE daily newsletter.

IKONICS (NASDAQ:IKNX) Frequently Asked Questions

How has IKONICS's stock been impacted by COVID-19 (Coronavirus)?

IKONICS's stock was trading at $3.98 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IKNX stock has decreased by 14.3% and is now trading at $3.41. View which stocks have been most impacted by Coronavirus.

When is IKONICS's next earnings date?

IKONICS is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for IKONICS.

How were IKONICS's earnings last quarter?

IKONICS Co. (NASDAQ:IKNX) posted its quarterly earnings results on Thursday, April, 30th. The specialty chemicals company reported ($0.11) earnings per share for the quarter. The specialty chemicals company earned $3.50 million during the quarter. IKONICS had a negative net margin of 5.38% and a negative return on equity of 4.76%. View IKONICS's earnings history.

Has IKONICS been receiving favorable news coverage?

Headlines about IKNX stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. IKONICS earned a news impact score of 1.2 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View the latest news about IKONICS.

Are investors shorting IKONICS?

IKONICS saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 500 shares, a decline of 37.5% from the May 31st total of 800 shares. Based on an average trading volume of 4,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.1% of the company's shares are sold short. View IKONICS's Current Options Chain.

Who are some of IKONICS's key competitors?

What other stocks do shareholders of IKONICS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IKONICS investors own include Consolidated Edison (ED), First Solar (FSLR), Marijuana Company Of America (MCOA), AbbVie (ABBV), Amplify Energy (AMPY), Amplify Energy (AMPY), TD Ameritrade (AMTD), BCE (BCE), Franklin Resources (BEN) and Bank of Nova Scotia (BNS).

Who are IKONICS's key executives?

IKONICS's management team includes the following people:
  • Mr. William C. Ulland, Chairman, CEO & Pres (Age 78)
  • Mr. Jon R. Gerlach, CFO, VP of Fin. & Sec. (Age 52)
  • Mr. Claude P. Piguet, Exec. VP (Age 61)
  • Mr. Kenneth D. Hegman, Chief Operating Officer (Age 48)

What is IKONICS's stock symbol?

IKONICS trades on the NASDAQ under the ticker symbol "IKNX."

How do I buy shares of IKONICS?

Shares of IKNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IKONICS's stock price today?

One share of IKNX stock can currently be purchased for approximately $3.41.

How big of a company is IKONICS?

IKONICS has a market capitalization of $6.74 million and generates $17.62 million in revenue each year. IKONICS employs 82 workers across the globe.

What is IKONICS's official website?

The official website for IKONICS is www.ikonics.com.

How can I contact IKONICS?

IKONICS's mailing address is 4832 GRAND AVENUE, DULUTH MN, 55807. The specialty chemicals company can be reached via phone at 218-628-2217 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.